Experience

Davis Polk is advising Mitsubishi Tanabe Pharma Corporation on its approximately $1.1 billion acquisition of NeuroDerm Ltd. The transaction, which is expected to close in the fourth quarter…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $7 billion aggregate principal amount of senior notes, consisting of $2 billion floating-rate…

Davis Polk advised the joint lead managers on an English law Regulation S only offering by ENN Energy Holdings Limited of its $600 million 3.25% bonds due 2022.  ENN Energy…

Davis Polk advised the underwriters in connection with an initial public offering of 17,968,750 shares of common stock of Akcea Therapeutics, Inc., including shares sold pursuant to the…

Davis Polk advised Neovia Logistics Services, LLC and Neovia Logistics Finance Corporation on their solicitation of consents to amend the indenture governing the 8.875% senior secured notes…

Davis Polk advised ORIX Corporation in connection with its SEC-registered shelf takedown of $750 million aggregate principal amount of 2.900% notes due 2022 and $500 million aggregate…

Davis Polk is advising Reckitt Benckiser Group plc on the sale of its Food Division to McCormick & Company Inc. for $4.2 billion in cash, subject to typical purchase price adjustments…

Davis Polk advised the initial purchasers in connection with the $200 million Regulation S offering by Central China Real Estate Limited of its 6.00% senior notes due 2018.  CCRE…

Davis Polk is advising China Vanke Co. in connection with its participation in a consortium to acquire all of the equity interests of Global Logistic Properties Ltd. (GLP) for approximately…

Davis Polk advised Longfor Properties Co. Ltd. in connection with its Regulation S only offering of $450 million 3.875% senior notes due 2022.  Longfor is engaged in property…